{Reference Type}: Journal Article
{Title}: Stenting of the Patent Ductus Arteriosus: A Meta-analysis and Literature Review.
{Author}: Bauser-Heaton H;Price K;Weber R;El-Said H;
{Journal}: J Soc Cardiovasc Angiogr Interv
{Volume}: 1
{Issue}: 6
{Year}: 2022 Nov-Dec
暂无{DOI}: 10.1016/j.jscai.2022.100392
{Abstract}: UNASSIGNED: Patent ductus arteriosus (PDA) stent placement and systemic-pulmonary surgical shunt procedure can both be performed as palliation for infants with duct-dependent pulmonary circulation. The aim of this meta-analysis and literature review was to compare outcomes and study populations between the 2 methods as well as review the technical considerations and complications of PDA stenting.
UNASSIGNED: A systematic search was conducted using the PubMed database and meta-analysis was performed. Risk ratio and mean difference were used to compare the reported outcomes of studies across patients receiving PDA stent and surgical shunt.
UNASSIGNED: In total, 1094 patients from 8 comparative observational studies were included. The PDA stent group had a lower mortality rate and a shorter hospital length of stay than the systemic-pulmonary surgical shunt group, although at the expense of increased reintervention rates. There were higher proportions of patients with single-ventricle physiology and single-source pulmonary blood flow in the surgical shunt group.
UNASSIGNED: PDA stenting appears to be a noninferior or possibly superior method of palliation for duct-dependent pulmonary circulation compared with systemic-pulmonary surgical shunt, recognizing, however, that patients receiving surgical shunt more often had single-ventricle physiology or single-source pulmonary blood flow in this meta-analysis.